These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37779834)

  • 41. Association between non-alcoholic fatty liver disease and subclinical coronary atherosclerosis: An observational cohort study.
    Lee SB; Park GM; Lee JY; Lee BU; Park JH; Kim BG; Jung SW; Jeong ID; Bang SJ; Shin JW; Park NH; Yang DH; Kang JW; Lim TH; Kim HK; Choe J; Lee HC
    J Hepatol; 2018 May; 68(5):1018-1024. PubMed ID: 29274406
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metabolic syndrome, fatty liver, and artificial intelligence-based epicardial adipose tissue measures predict long-term risk of cardiac events: a prospective study.
    Lin A; Wong ND; Razipour A; McElhinney PA; Commandeur F; Cadet SJ; Gransar H; Chen X; Cantu S; Miller RJH; Nerlekar N; Wong DTL; Slomka PJ; Rozanski A; Tamarappoo BK; Berman DS; Dey D
    Cardiovasc Diabetol; 2021 Jan; 20(1):27. PubMed ID: 33514365
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nonalcoholic fatty liver disease is associated with coronary artery calcification: A systematic review and meta-analysis.
    Jaruvongvanich V; Wirunsawanya K; Sanguankeo A; Upala S
    Dig Liver Dis; 2016 Dec; 48(12):1410-1417. PubMed ID: 27697419
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic value of non-alcoholic fatty liver disease for predicting cardiovascular events in patients with diabetes mellitus with suspected coronary artery disease: a prospective cohort study.
    Ichikawa K; Miyoshi T; Osawa K; Miki T; Toda H; Ejiri K; Yoshida M; Nanba Y; Yoshida M; Nakamura K; Morita H; Ito H
    Cardiovasc Diabetol; 2021 Jan; 20(1):8. PubMed ID: 33413363
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The correlation between hepatic fat fraction evaluated by dual-energy computed tomography and high-risk coronary plaques in patients with non-alcoholic fatty liver disease.
    Zhan R; Qi R; Huang S; Lu Y; Wang X; Jiang J; Ruan X; Song A
    Jpn J Radiol; 2021 Aug; 39(8):763-773. PubMed ID: 33818707
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Correlation between CT Abdominal Anthropometric Measurements and Liver Density in Individuals with Non-Alcoholic Fatty Liver Disease.
    Cucoranu DC; Pop M; Niculescu R; Vunvulea V; Kosovski IB; Togănel RO; Russu E; Mureșan AV; Licu RA; Bacârea A
    Medicina (Kaunas); 2023 Mar; 59(3):. PubMed ID: 36984501
    [No Abstract]   [Full Text] [Related]  

  • 47. Visual Ordinal Scoring of Coronary Artery Calcium on Contrast-Enhanced and Noncontrast Chest CT: A Retrospective Study of Diagnostic Performance and Prognostic Utility.
    Fresno CU; Tijmes FS; Thavendiranathan P; Akhtari S; Karur GR; Torres FS; Halankar J; Nguyen ET; Hanneman K
    AJR Am J Roentgenol; 2022 Oct; 219(4):569-578. PubMed ID: 35475394
    [No Abstract]   [Full Text] [Related]  

  • 48. The association of the steatosis severity in fatty liver disease with coronary plaque pattern in general population.
    Hsu PF; Wang YW; Lin CC; Wang YJ; Ding YZ; Liou TL; Huang SS; Lu TM; Chan WL; Lin SJ; Leu HB
    Liver Int; 2021 Jan; 41(1):81-90. PubMed ID: 33373113
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Morphomic calcification score from clinical CT scans: A proxy for coronary artery calcium.
    Horbal SR; Rossman AH; Brown E; Shah NV; Ross BE; Bidulescu A; Sullivan JA; Su GL; Wang SC
    Clin Imaging; 2020 Oct; 66():57-63. PubMed ID: 32450484
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Estimation of cardiovascular risk on routine chest CT: Ordinal coronary artery calcium scoring as an accurate predictor of Agatston score ranges.
    Azour L; Kadoch MA; Ward TJ; Eber CD; Jacobi AH
    J Cardiovasc Comput Tomogr; 2017; 11(1):8-15. PubMed ID: 27743881
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Density and morphology of coronary artery calcium for the prediction of cardiovascular events: insights from the Framingham Heart Study.
    Foldyna B; Eslami P; Scholtz JE; Baltrusaitis K; Lu MT; Massaro JM; D'Agostino RB; Ferencik M; Aerts HJWL; O'Donnell CJ; Hoffmann U
    Eur Radiol; 2019 Nov; 29(11):6140-6148. PubMed ID: 31049733
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of metabolic factors on risk of cardiovascular disease in nondiabetic metabolic dysfunction-associated fatty liver disease.
    Kang MK; Lee YR; Jang SY; Tak WY; Kweon YO; Song JE; Loomba R; Park SY; Park JG
    Hepatol Int; 2023 Jun; 17(3):626-635. PubMed ID: 37069419
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Coronary artery calcium on standard chest computed tomography predicts cardiovascular events after liver transplantation.
    Zorzi A; Brunetti G; Cardaioli F; D'Arcangelo F; Fabris T; Gambato M; Iliceto S; Martini A; Mattesi G; Peluso C; Polacco M; Sartori C; Lorenzoni G; Feltracco P; Angeli P; Burra P; Cillo U; Pontisso P
    Int J Cardiol; 2021 Sep; 339():219-224. PubMed ID: 34181996
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Liver Fibrosis Scores and Coronary Artery Disease: Novel Findings in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease.
    Lu C; Chen Y; Zhang Y; Zhao X
    Diabetes Metab Syndr Obes; 2023; 16():2627-2637. PubMed ID: 37663203
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Coronary artery calcification scoring system based on the coronary artery calcium data and reporting system (CAC-DRS) predicts major adverse cardiovascular events or all-cause death in patients with potentially curable lung cancer without a history of cardiovascular disease.
    Osawa K; Bessho A; Fuke S; Moriyama S; Mizobuchi A; Daido S; Tanaka M; Yumoto A; Saito H; Ito H
    Heart Vessels; 2020 Nov; 35(11):1483-1493. PubMed ID: 32444933
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Correlation between nonalcoholic fatty liver disease and coronary atherosclerosis.
    Vu H; Khanh Tuong TT; Hoang Lan N; Quoc Thang T; Bilgin K; Hoa T; Minh Duc N
    Clin Ter; 2022; 173(6):565-571. PubMed ID: 36373456
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transient elastography and serum markers of liver fibrosis associate with epicardial adipose tissue and coronary artery calcium in NAFLD.
    Perdomo CM; Ezponda A; Núñez-Córdoba JM; Herrero JI; Bastarrika G; Frühbeck G; Escalada J
    Sci Rep; 2022 Apr; 12(1):6564. PubMed ID: 35449229
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The associations between coronary artery disease, and non-alcoholic fatty liver disease by computed tomography.
    Saraya S; Saraya M; Mahmoud M; Galal M; Soliman HH; Raafat M
    Egypt Heart J; 2021 Oct; 73(1):96. PubMed ID: 34718898
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association of coronary artery calcification with liver fibrosis in Japanese patients with non-alcoholic fatty liver disease.
    Ishiba H; Sumida Y; Kataoka S; Kuroda M; Akabame S; Tomiyasu K; Tanaka M; Arai M; Taketani H; Seko Y; Okajima A; Hara T; Umemura A; Nishikawa T; Yamaguchi K; Moriguchi M; Mitsuyoshi H; Yasui K; Itoh Y
    Hepatol Res; 2016 Oct; 46(11):1107-1117. PubMed ID: 26853695
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Incremental prognostic value of non-alcoholic fatty liver disease over coronary computed tomography angiography findings in patients with suspected coronary artery disease.
    Ichikawa K; Miyoshi T; Osawa K; Miki T; Toda H; Ejiri K; Yoshida M; Nakamura K; Morita H; Ito H
    Eur J Prev Cardiol; 2022 Feb; 28(18):2059-2066. PubMed ID: 34279027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.